Ledger.Open graph →
SEC Form D · Amendment · filed November 13, 2014

Tolero Pharmaceuticals, Inc

Offering
$35.5M
Sold
$21.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Lehi, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Dallin Anderson · Lehi, UTExec · Director · PromoterDavid Bearss, Ph.D · Lehi, UTExec · Director · PromoterScott Perekslis · New York, NYExec · Director · PromoterJoseph Shepherd · GOLDEN, COExec · Director · PromoterNoah Pittard · GOLDEN, COExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗